Page 20 - மருந்தியல் ஆபத்து மதிப்பீடு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Follow RT on Five cases of a very rare blood disorder in people who have received the Covid-19 vaccine developed by AstraZeneca are being reviewed by the European Medicines Agency (EMA), the EU s drug regulator has said. The cases of capillary leak syndrome, which can cause leakage of fluid from blood vessels, tissue swelling and a drop in blood pressure, were reported from across the European Economic Area, the EMA said on Friday. The regulator said it is The EMA said the five cases, all reported in the European Economic Area, warrant further investigation and potentially an update to the vaccine s product information, if deemed necessary by its Pharmacovigilance Risk Assessment Committee (PRAC).

United kingdomAstrazeneca covidAstrazeneca vaxzevriaJohnson covidPharmacovigilance risk assessment committeeEuropean economic areaஒன்றுபட்டது கிஂக்டம்மருந்தியல் ஆபத்து மதிப்பீடு குழுஐரோப்பிய பொருளாதார பரப்பளவு